The abilities of our technology in a bioprocessing environment allows the user to promptly characterise important Critical Quality Attributes (CQA) of the biologic products and monitor Critical Process Parameters (CPP) within the bioprocess itself. This enables timely decisions to be made about how best to intervene in the workflow in real-time. As a result, our miniaturised platform leads to more robust yet agile biologics processing and manufacturing.

A key enabler of QbD, our analyser provides access to process and product information in real-time, and increases the probability of successfully completing the biologics manufacturing process

Key benefits

  • Faster decision-making for bioprocessing optimisation
  • Automated, continuous and more robust biologics manufacturing and supply
  • An enabler for Quality-by-Design, providing real-time process analysis capability for CPP and CQA
  • Lower cost of biologics production and supply as a result of an enhanced process control strategy

Our kit is now set up and ready to go with @Modern_Water in China! #msys @DeepVerge https://t.co/MxH7yxZJN5@Microsaic 26 November 2021